WallStSmart
NVNO

enVVeno Medical Corp

NASDAQ: NVNO · HEALTHCARE · MEDICAL DEVICES

$8.75
+7.03% today

Updated 2026-10-09

Market cap
$5.99M
P/E ratio
—
P/S ratio
216.91x
EPS (TTM)
$-24.45
Dividend yield
—
52W range
$7 – $35
Volume
0.0M

enVVeno Medical Corp (NVNO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201420152016201720182019202020212022202320242025
Operating cash flow$121.00$-2.02M$-3.42M$-4.20M$-6.36M$-5.90M$-7.68M$-11.85M$-15.62M$-18.86M$-16.84M$-15.57M
Capital expenditures$30.00$2620.00$373616.00$10938.00$12422.00$363891.00$180291.00$368000.00$115000.00$33000.00$37000.00$5000.00
Depreciation————————————
Stock-based comp——$1.51M$878404.00$1.92M$941964.00$881213.00$6.00M$8.99M$5.20M$4.14M$3.42M
Free cash flow$91.00$-2.02M$-3.79M$-4.21M$-6.37M$-6.26M$-7.86M$-12.22M$-15.73M$-18.89M$-16.88M$-15.57M
Investing cash flow————————————
Financing cash flow————————————
Dividends paid————————————
Share repurchases————————————
Debt repayment————————————
Net change in cash————————$-50.17M———

Frequently asked questions

How much free cash flow does NVNO generate?

NVNO produced $-15.57M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NVNO's balance sheet healthy?

NVNO holds $3.06M in cash and equivalents against — in long-term debt, on $27.13M of shareholder equity. That debt is best read against the cash flow the business throws off each year.